Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer
Crossref DOI link: https://doi.org/10.1007/s00520-017-3689-5
Published Online: 2017-04-20
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Korkeila, E. A.
Salminen, T.
Kallio, R.
Mikkola, M.
Auvinen, P.
Pyrhönen, S.
Ristamäki, R.
Funding for this research was provided by:
Sanofi Genzyme
License valid from 2017-04-20